October 31, 2024
TOPLINE: Fidanacogene elaparvovec gene therapy reduced the annualized bleeding rate by 71% in patients with hemophilia B. Factor IX activity levels were sustained at 26.9% at […]
October 31, 2024
When psychiatrist Paul Sartain, MD (not his real name), received a letter from his state’s medical board, he was concerned. A patient’s family complained that he […]
October 31, 2024
TOPLINE: Trastuzumab duocarmazine (T-Duo) improved progression-free survival to 7.0 months compared with 4.9 months with a physician’s choice in advanced human epidermal growth factor receptor 2–positive […]
October 31, 2024
If standard therapies don’t give relief to patients with refractory cough associated with interstitial lung disease, maybe a little poison could do the trick. Among 41 […]
October 31, 2024
New guidelines are out for researchers and others for how to use information about race and ethnicity in biomedical research, with implications for practicing clinicians. Race […]
October 31, 2024
TOPLINE: Patients with cutaneous lupus erythematosus (CLE) experienced improved symptoms with iberdomide, a cereblon modulator, added to standard lupus medications, particularly in subacute and chronic cases. […]
October 31, 2024
TOPLINE: Patients with erythropoietic protoporphyria (EPP) have a higher prevalence of low bone mineral density (BMD) than the general healthy population, but BMD improves with cholecalciferol […]
October 31, 2024
Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) prior to bariatric surgery was safe but wasn’t associated with greater weight loss than bariatric surgery alone, […]
October 31, 2024
Antipsychotics are the best defense against relapse in schizophrenia, even though that protection often comes at the expense of cognitive function. Which drugs offer the greatest […]